Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions
- PMID: 14508395
- DOI: 10.1097/00000478-200310000-00006
Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions
Abstract
This study investigates differences in expression of the cell cycle/growth activation markers p53, p16, and p27, and their relationship with nerve sheath cell and proliferation markers among plexiform neurofibromas (PNF), NF1-related and non-NF1 MPNSTs of different histologic grades and between benign-appearing and malignant areas in the MPNSTs associated with PNFs. Formalin-fixed, paraffin-embedded archival tissue from PNFs and MPNSTs were immunostained using the avidin-biotin-complex method with antibodies to S-100 protein (S-100), Leu7 (CD57), CD34, p16, p27, p53, Mib-1, and topoisomerase II-alpha (TopoIIalpha), with appropriate controls. All PNFs and most low-grade MPNSTs displayed diffuse or focal reactivity for S-100, Leu7, CD34, p16, and p27 and negative reactivity for p53, Mib-1, and TopoIIalpha. Most high-grade MPNSTs displayed decreased or negative reactivity to S-100, Leu7, CD34, p16, and p27 but increased reactivity to p53 (59%), Mib-1 (72%), and TopoIIalpha (72%). In addition, combined nuclear and cytoplasmic (nucleocytoplasmic) p27 staining, which was not seen in the PNF or low-grade MPNST, was observed in 33% of high-grade MPNSTs. These findings suggest that p53, p16, and p27 may be involved in tumor progression in the PNF-MPNST sequence. However, alterations in p53, p16, and p27 do not distinguish between low-grade MPNST and PNF, including PNF adjacent to high-grade MPNST. Although p53, p16, and p27 are unlikely to be reliable markers for early detection of tumor progression in MPNST, p53 reactivity was more frequent in NF1-associated high-grade MPNST and appeared to be a marker for high tumor grade. Combining immunohistochemical stains with histologic grading with careful examination of mitotic activity may provide insight into the progression of peripheral nerve sheath tumors.
Similar articles
-
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.Hum Pathol. 2017 Sep;67:1-10. doi: 10.1016/j.humpath.2017.05.010. Epub 2017 May 24. Hum Pathol. 2017. PMID: 28551330 Free PMC article. Review.
-
Malignant Peripheral Nerve Sheath Tumor.Surg Oncol Clin N Am. 2016 Oct;25(4):789-802. doi: 10.1016/j.soc.2016.05.009. Surg Oncol Clin N Am. 2016. PMID: 27591499 Review.
-
Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.Anticancer Res. 2007 Jul-Aug;27(4A):2085-90. Anticancer Res. 2007. PMID: 17649826
-
Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.J Neuropathol Exp Neurol. 2005 Jan;64(1):74-81. doi: 10.1093/jnen/64.1.74. J Neuropathol Exp Neurol. 2005. PMID: 15715087
-
Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.Mod Pathol. 1998 Jul;11(7):612-7. Mod Pathol. 1998. PMID: 9688181
Cited by
-
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?Mol Ther Oncolytics. 2023 Jul 31;30:227-237. doi: 10.1016/j.omto.2023.07.008. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37680255 Free PMC article. Review.
-
Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management.Cancers (Basel). 2023 Feb 8;15(4):1077. doi: 10.3390/cancers15041077. Cancers (Basel). 2023. PMID: 36831419 Free PMC article. Review.
-
CDX2 expression in malignant peripheral nerve sheath tumour: a potential diagnostic pitfall associated with PRC2 inactivation.Histopathology. 2022 May;80(6):995-1000. doi: 10.1111/his.14626. Epub 2022 Feb 28. Histopathology. 2022. PMID: 35122289 Free PMC article.
-
Parotid Neurogenic Tumors: MPNST Sarcoma to Schwannoma-Review of Literature and Guidelines in Management.J Maxillofac Oral Surg. 2021 Sep;20(3):356-363. doi: 10.1007/s12663-021-01523-2. Epub 2021 Mar 23. J Maxillofac Oral Surg. 2021. PMID: 34408362 Free PMC article. Review.
-
Malignant Peripheral Nerve Sheath Tumor of the Cerebellar Hemisphere: An Unusual Location and Multiple Intracranial Parenchyma Metastases.Cureus. 2021 Apr 8;13(4):e14373. doi: 10.7759/cureus.14373. Cureus. 2021. PMID: 33976994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous